Compound Detail
CHEMBL4756120
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4756120 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ARBCCEGUPRPKBE-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
395.5
MW (Da)
2.34
ALogP
7
HBA
3
HBD
129.3
PSA (Ų)
0.56
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.91
IC50 1 meas. best 10.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 10.0 | 10.0 | 0.1 | 1 |
| Cryptosporidium parvum CHEMBL612855 | EC50 | 5.91 | 5.91 | 1220.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 0.1 | nM | 10.0 | Inhibition of Cryptosporidium parvum CDPK1 assessed as reduction in ATP consumpt... | 30830766 |
| Cryptosporidium parvum | EC50 | = | 1220.0 | nM | 5.91 | Antimicrobial activity against nano-luciferase-expressing Cryptosporidium parvum... | 30830766 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30830766 | 10.1021/acs.jmedchem.9b00069 | ADMET | 2 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | No relevant target | 2 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | Unchecked | 2 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | HepG2 | 1 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | Cryptosporidium parvum | 1 |
| 30830766 | 10.1021/acs.jmedchem.9b00069 | Proto-oncogene tyrosine-protein kinase Src | 1 |
Data from ChEMBL 36 via Core Engine